Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04251481 · ClinicalTrials.gov registry record · NA
Diffusion MRI for Head and Neck Cancer
A NA study of Head Cancer Neck, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 2
- Study locations
NCT04251481 is a NA study of Head Cancer Neck that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 16 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT04251481, a NA study of Head Cancer Neck, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 2
- Study locations
Study Summary
The proposed study is to investigate the feasibility of using quantitative diffusion MRI (dMRI) methods for accurate and comprehensive assessment of treatment response. dMRI is a powerful tool to probe treatment-induced change in tumors. It is a unique in vivo imaging technique sensitive to cellular microstructures at the scale of water diffusion length on the order of a few microns. Previous studies have shown that both diffusion coefficient D and diffusional kurtosis coefficient K are promising imaging markers of (i) cell viability which can be used for evaluation of early treatment response. However, it is often underappreciated that these dMRI metrics are not fixed constants, but rather functions of the diffusion time t, D(t) and K(t); their t-dependency is determined by tissue properties, such as cell size and membrane permeability of tissue. D(t) and K(t) of tumors can vary substantially depending on t in the range of diffusion times (30-100 ms) typically used in clinical scan.
Conditions Studied
Interventions
- RADIATION PET/MRI with FDG
- RADIATION MRI scan without contrast
- RADIATION MRI with gadolinium
Study Locations (2)
New York
- NYU Langone - New York
- Weill Cornell Medical College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-10-16 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04251481
The ClinicalTrials.gov registry entry for NCT04251481 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Head Cancer Neck appearing as the primary indexed condition, and to 3 interventions - of which PET/MRI with FDG is the first listed.
NCT04251481 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04251481 about?
NCT04251481 is a clinical study titled "Diffusion MRI for Head and Neck Cancer". The proposed study is to investigate the feasibility of using quantitative diffusion MRI (dMRI) methods for accurate and comprehensive assessment of treatment response. dMRI is a powerful tool to probe treatment-induced change in tumors. It is a unique in vivo imaging technique sensitive to cellular...
What is the current status of trial NCT04251481?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2019-10-16. Estimated completion is 2026-04-30.
What conditions does trial NCT04251481 study?
This clinical trial studies the following conditions: Head Cancer Neck.
What interventions are being tested in trial NCT04251481?
The interventions under investigation include: PET/MRI with FDG (RADIATION), MRI scan without contrast (RADIATION), MRI with gadolinium (RADIATION).
Who is sponsoring clinical trial NCT04251481?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04251481 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head Cancer Neck
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.